Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging

Backgrounds: Non-small cell lung cancer (NSCLC) prognosis remains poor despite treatment advances, and classical prognostic indicators often fall short in precision medicine. Transforming acidic coiled-coil protein-3 (TACC3) has been identified as a critical factor in tumor progression and immune in...

Full description

Saved in:
Bibliographic Details
Main Authors: Weichao Bai, Xinhan Zhao, Qian Ning
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Translational Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523324003383
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846136469281832960
author Weichao Bai
Xinhan Zhao
Qian Ning
author_facet Weichao Bai
Xinhan Zhao
Qian Ning
author_sort Weichao Bai
collection DOAJ
description Backgrounds: Non-small cell lung cancer (NSCLC) prognosis remains poor despite treatment advances, and classical prognostic indicators often fall short in precision medicine. Transforming acidic coiled-coil protein-3 (TACC3) has been identified as a critical factor in tumor progression and immune infiltration across cancers, including NSCLC. Predicting TACC3 expression through radiomic features may provide valuable insights into tumor biology and aid clinical decision-making. However, its predictive value in NSCLC remains unexplored. Therefore, we aimed to construct and validate a radiomic model to predict TACC3 levels and prognosis in patients with NSCLC. Materials and methods: Genomic data and contrast-enhanced computed tomography (CT) images were sourced from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) database, and The Cancer Imaging Archive (TCIA). A total of 320 cases of lung adenocarcinoma from TCGA and 122 cases of NSCLC from GEO were used for prognostic analysis. Sixty-three cases from TCIA and GEO were included for radiomics feature extraction and model development. The radiomics model was constructed using logistic regression (LR) and support vector machine (SVM) algorithms. We predicted TACC3 expression and evaluated its correlation with NSCLC prognosis using contrast-enhanced CT-based radiomics. Results: TACC3 expression significantly influenced NSCLC prognosis. High TACC3 levels were associated with reduced overall survival, potentially mediated by immune microenvironment and tumor progression regulation. LR and SVM algorithms achieved AUC of 0.719 and 0.724, respectively, which remained at 0.701 and 0.717 after five-fold cross-validation. Conclusion: Contrast-enhanced CT-based radiomics can non-invasively predict TACC3 expression and provide valuable prognostic information, contributing to personalized treatment strategies.
format Article
id doaj-art-6b00f76c8e284bb583330d36fa6a8a8d
institution Kabale University
issn 1936-5233
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Translational Oncology
spelling doaj-art-6b00f76c8e284bb583330d36fa6a8a8d2024-12-09T04:27:13ZengElsevierTranslational Oncology1936-52332025-01-0151102211Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imagingWeichao Bai0Xinhan Zhao1Qian Ning2Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province 710061, ChinaDepartment of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province 710061, ChinaDepartment of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi Province 710061, China; Corresponding author.Backgrounds: Non-small cell lung cancer (NSCLC) prognosis remains poor despite treatment advances, and classical prognostic indicators often fall short in precision medicine. Transforming acidic coiled-coil protein-3 (TACC3) has been identified as a critical factor in tumor progression and immune infiltration across cancers, including NSCLC. Predicting TACC3 expression through radiomic features may provide valuable insights into tumor biology and aid clinical decision-making. However, its predictive value in NSCLC remains unexplored. Therefore, we aimed to construct and validate a radiomic model to predict TACC3 levels and prognosis in patients with NSCLC. Materials and methods: Genomic data and contrast-enhanced computed tomography (CT) images were sourced from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) database, and The Cancer Imaging Archive (TCIA). A total of 320 cases of lung adenocarcinoma from TCGA and 122 cases of NSCLC from GEO were used for prognostic analysis. Sixty-three cases from TCIA and GEO were included for radiomics feature extraction and model development. The radiomics model was constructed using logistic regression (LR) and support vector machine (SVM) algorithms. We predicted TACC3 expression and evaluated its correlation with NSCLC prognosis using contrast-enhanced CT-based radiomics. Results: TACC3 expression significantly influenced NSCLC prognosis. High TACC3 levels were associated with reduced overall survival, potentially mediated by immune microenvironment and tumor progression regulation. LR and SVM algorithms achieved AUC of 0.719 and 0.724, respectively, which remained at 0.701 and 0.717 after five-fold cross-validation. Conclusion: Contrast-enhanced CT-based radiomics can non-invasively predict TACC3 expression and provide valuable prognostic information, contributing to personalized treatment strategies.http://www.sciencedirect.com/science/article/pii/S1936523324003383Contrast-enhanced computed tomographyRadiomicsTransforming acidic coiled-coil protein-3Non-small cell lung cancerClinical prognosis
spellingShingle Weichao Bai
Xinhan Zhao
Qian Ning
Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging
Translational Oncology
Contrast-enhanced computed tomography
Radiomics
Transforming acidic coiled-coil protein-3
Non-small cell lung cancer
Clinical prognosis
title Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging
title_full Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging
title_fullStr Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging
title_full_unstemmed Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging
title_short Development and validation of a radiomic prediction model for TACC3 expression and prognosis in non-small cell lung cancer using contrast-enhanced CT imaging
title_sort development and validation of a radiomic prediction model for tacc3 expression and prognosis in non small cell lung cancer using contrast enhanced ct imaging
topic Contrast-enhanced computed tomography
Radiomics
Transforming acidic coiled-coil protein-3
Non-small cell lung cancer
Clinical prognosis
url http://www.sciencedirect.com/science/article/pii/S1936523324003383
work_keys_str_mv AT weichaobai developmentandvalidationofaradiomicpredictionmodelfortacc3expressionandprognosisinnonsmallcelllungcancerusingcontrastenhancedctimaging
AT xinhanzhao developmentandvalidationofaradiomicpredictionmodelfortacc3expressionandprognosisinnonsmallcelllungcancerusingcontrastenhancedctimaging
AT qianning developmentandvalidationofaradiomicpredictionmodelfortacc3expressionandprognosisinnonsmallcelllungcancerusingcontrastenhancedctimaging